Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | YBL-006 |
Trade Name | |
Synonyms | YBL006|YBL 006 |
Drug Descriptions |
YBL-006 is a monoclonal antibody that binds to PD-1 (PDCD1) and blocks its interaction with PD-L1 (CD274) and PD-L2 (PDCD1LG2), potentially leading to enhanced immune response and inhibition of tumor growth (Cancer Res 2020;80(16 Suppl):Abstract nr 3367). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
YBL-006 | YBL-006 | 0 | 1 |